Feedback / Questions
FKB238 (bevacizumab biosimilar) - Fujifilm Kyowa Kirin Biologics, AstraZeneca
Kyowa Hakko Kirin: Q3 FY 2013 Results
(Kyowa Hakko Kirin Pharma)
-
Nov 1, 2013 -
Anticipated initiation of new trial for cancer in 2014
Anticipated new trial
•
Biosimilar • Colorectal Cancer
http://www.kyowa-kirin.com/investors/financial_summary_presentations/pdf/earning2013e_q3_presentation.pdf
Nov 1, 2013
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.